Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00993135 · ClinicalTrials.gov registry record
Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 10
- Enrollment target
NCT00993135 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT00993135 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about how often kidney dysfunction occurs in children and young adults receiving methotrexate for acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment. PURPOSE: This research study is looking at kidney dysfunction in children and young adults who have received low-dose or intermediate-dose methotrexate for acute lymphoblastic leukemia.
Interventions
- OTHER medical chart review
- DRUG methotrexate
- PROCEDURE assessment of therapy complications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00993135
The ClinicalTrials.gov registry entry for NCT00993135 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which medical chart review is the first listed.
NCT00993135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00993135 about?
NCT00993135 is a clinical study titled "Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia". RATIONALE: Gathering information about how often kidney dysfunction occurs in children and young adults receiving methotrexate for acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment. PURPOSE: This research study is looking at kidney dysfunction in...
What is the current status of trial NCT00993135?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2008-12.
What interventions are being tested in trial NCT00993135?
The interventions under investigation include: medical chart review (OTHER), methotrexate (DRUG), assessment of therapy complications (PROCEDURE).
Who is sponsoring clinical trial NCT00993135?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.